Table of contents
September 2007 Vol 7 No 9
From the editors
p655 | doi:10.1038/nri2168
Research Highlights
B–cell responses: Pass the parcel | PDF (200 KB)
p657 | doi:10.1038/nri2160
Parasite immunity: Arming T cells early | PDF (148 KB)
p658 | doi:10.1038/nri2165
T cells: Notch and GATA3 join forces | PDF (320 KB)
p658 | doi:10.1038/nri2167
Autoimmunity: Monocytes take centre stage | PDF (116 KB)
p659 | doi:10.1038/nri2166
Immune evasion: Evasive manoeuvres | PDF (319 KB)
p660 | doi:10.1038/nri2157
Immune regulation: Linking integrins, TGF
and autoimmunity | PDF
(174 KB)
p660 | doi:10.1038/nri2162
In the news
Genes and vaccine for multiple sclerosis | PDF (100 KB)
p660 | doi:10.1038/nri2164
In brief
| PDF (118 KB)
p661 | doi:10.1038/nri2170
Tumour immunology: Innate immune activation enhances tumour immunotherapy | PDF (233 KB)
p662 | doi:10.1038/nri2158
T cells: New regulator of calcium signalling | PDF (361 KB)
p662 | doi:10.1038/nri2169
Chemokines: Dictating migration | PDF (443 KB)
p663 | doi:10.1038/nri2159
Reviews
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease
Stephen D. Miller, Danielle M. Turley & Joseph R. Podojil
p665 | doi:10.1038/nri2153
Therapeutic strategies that induce antigen-specific immune tolerance without suppressing the ability of the immune system to respond to infectious agents are needed for the treatment of autoimmune diseases. But how might these antigen-specific therapies induce tolerance and are they safe for use in the clinic?
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley, Carlo Laudanna, Myron I. Cybulsky & Sussan Nourshargh
p678 | doi:10.1038/nri2156
To get to the site of inflammation, leukocytes must first adhere to and traverse the blood-vessel wall, events that occur in a cascade-like manner. But what are the exact steps in this cascade and what molecules are involved?
Calcium signalling in lymphocyte activation and disease
Stefan Feske
p690 | doi:10.1038/nri2152
Recently, two key regulators of calcium influx in lymphocytes were discovered — STIM and ORAI. How this has advanced our understanding of calcium signalling in lymphocytes and the pathological consequences of disruption of this pathway are discussed in this Review.
Developmental pathways that generate natural-killer-cell diversity in mice and humans
Nicholas D. Huntington, Christian A. J. Vosshenrich & James P. Di Santo
p703 | doi:10.1038/nri2154
Natural killer (NK) cells perform multiple functional activities, including rapid cytokine production and spontaneous cytotoxicity. James Di Santo and colleagues review the evidence that such functional heterogeneity arises from the development of diverse NK-cell subsets with unique biological roles.
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian & Shreeram Akilesh
p715 | doi:10.1038/nri2155
Although best known for its role in mother-to-child IgG transfer, new roles for the neonatal Fc receptor for IgG (FcRn) are emerging. Its role in regulating serum antibody half-life in adults has important implications for autoimmune diseases and antibody-based biologicals.
Sonic hedgehog signalling in T-cell development and activation
Tessa Crompton, Susan V. Outram & Ariadne L. Hager-Theodorides
p726 | doi:10.1038/nri2151
Hedgehog signalling proteins, and in particular sonic hedgehog, have a role in T-cell development in the thymus and in peripheral T-cell activation, but, as outlined here, some aspects of their functions remain controversial.
Perspective
Opinion
Promiscuity and the single receptor: NKG2D
Robert A. Eagle & John Trowsdale
p737 | doi:10.1038/nri2144
The activating receptor NKG2D (natural-killer group 2, member D) recognizes an array of ligands that are upregulated by cellular stress. But what value is it for the host to express so many ligands for one receptor, and what drives NKG2D-ligand diversity?


